Pages that link to "Q43970140"
Jump to navigation
Jump to search
The following pages link to Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity (Q43970140):
Displaying 26 items.
- Receptor Ck-dependent signaling regulates hTERT gene transcription. (Q25255748) (← links)
- Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases (Q28071309) (← links)
- The non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell lines (Q28238709) (← links)
- Deficiency in Cardiolipin Reduces Doxorubicin-Induced Oxidative Stress and Mitochondrial Damage in Human B-Lymphocytes (Q28552702) (← links)
- 4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity. (Q30414471) (← links)
- Transcription profiling of lung adenocarcinomas of c-myc-transgenic mice: identification of the c-myc regulatory gene network (Q33337226) (← links)
- Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes. (Q33692555) (← links)
- Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism (Q35124419) (← links)
- Peroxisome proliferator-activated receptors and cancer: challenges and opportunities (Q35210023) (← links)
- Crosstalk of oncogenic and prostanoid signaling pathways (Q35810119) (← links)
- T cell factor-4 functions as a co-activator to promote NF-κB-dependent MMP-15 expression in lung carcinoma cells (Q36765065) (← links)
- Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignancies (Q37182794) (← links)
- The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products (Q37211832) (← links)
- Smac mimetic induces cell death in a large proportion of primary acute myeloid leukemia samples, which correlates with defined molecular markers (Q37580273) (← links)
- Effects of PPARγ Ligands on Leukemia (Q38017661) (← links)
- Peroxisome Proliferator-Activated Receptor Ligands and Their Role in Chronic Myeloid Leukemia: Therapeutic Strategies. (Q38721726) (← links)
- Can an oral antidiabetic (rosiglitazone) be of benefit in leukemia treatment? (Q38909191) (← links)
- New insights into antidiabetic drugs: Possible applications in cancer treatment. (Q39272833) (← links)
- Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival. (Q39639581) (← links)
- Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells (Q40066974) (← links)
- 15-deoxy-(Delta12,14)-prostaglandin J2 (15d-PGJ2) induces cell death through caspase-independent mechanism in A172 human glioma cells (Q40226575) (← links)
- Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18). (Q40261116) (← links)
- Hepatocyte growth factor protects small airway epithelial cells from apoptosis induced by tumor necrosis factor-alpha or oxidative stress (Q40544580) (← links)
- Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells (Q41905030) (← links)
- PPARγ and Oxidative Stress: Con(β) Catenating NRF2 and FOXO (Q42560760) (← links)
- Troglitazone-induced liver failure: a case study (Q44394235) (← links)